As SH3GL2 and FKBP12 may be potential effectors in PD; therefore, investigating DNM1-associated pathways could provide new insights to target the impairments in synaptic transmission in transplantation therapeutic interventions. This evidence concerns the gene SH3GL2 and Parkinson disease.